PA
Paradigm Bio
PAR.AX·ASXMelbourne AUFounded 201530 employees
Micro CapbiotechPublicMusculoskeletal
Platform: PPS Tendon
Market Cap
$0.08B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (PAR.AX)
Loading PAR.AX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| PAR-6401 | PAR-6401 | Phase 1 | 1 | TNFα | PsA | ||
| Motamavacamten | PAR-6166 | Preclinical | 1 | JAK1 | PBCEpilepsy |
SEC Filings & Financial Documents
SEC filings are not available for ASX-listed companies.
Paradigm Bio trades on ASX (AU). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)